Annual ROE
1905.22%
+2956.25%+281.27%
December 1, 2023
Summary
- As of February 23, 2025, CYTO annual return on equity is 1905.22%, with the most recent change of +2956.25% (+281.27%) on December 1, 2023.
- During the last 3 years, CYTO annual ROE has risen by +1954.12% (+3996.16%).
- CYTO annual ROE is now at all-time high.
Performance
CYTO ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
N/A
June 1, 2024
Summary
- CYTO quarterly return on equity is not available.
Performance
CYTO Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
CYTO ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +281.3% | - |
| 3 y3 years | +3996.2% | - |
| 5 y5 years | +704.8% | - |
CYTO ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +281.3% | ||
| 5 y | 5-year | at high | +281.3% | ||
| alltime | all time | at high | +281.3% |
Altamira Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | 1905.22%(-281.3%) | - |
| Dec 2022 | -1051.03%(+842.0%) | -643.70%(+380.1%) |
| Jun 2022 | - | -134.07%(-19.9%) |
| Dec 2021 | -111.58%(+128.2%) | - |
| Dec 2020 | -48.90%(-55.5%) | - |
| Dec 2019 | -109.87%(-65.1%) | - |
| Jun 2019 | - | -167.39%(-107.5%) |
| Dec 2018 | -315.00%(-127.9%) | 2237.91%(+253.8%) |
| Sep 2018 | - | 632.56%(-22.5%) |
| Jun 2018 | - | 815.83%(-115.5%) |
| Mar 2018 | - | -5264.93%(+608.5%) |
| Dec 2017 | 1128.92% | -743.12%(+126.5%) |
| Sep 2017 | - | -328.09%(+56.5%) |
| Jun 2017 | - | -209.62%(+29.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2017 | - | -161.80%(+33.2%) |
| Dec 2016 | -216.80%(+226.6%) | -121.48%(+27.0%) |
| Sep 2016 | - | -95.64%(+36.4%) |
| Jun 2016 | - | -70.10%(+7.5%) |
| Mar 2016 | - | -65.22%(+7.9%) |
| Dec 2015 | -66.39%(+94.5%) | -60.43%(+10.3%) |
| Sep 2015 | - | -54.80%(+11.5%) |
| Jun 2015 | - | -49.13%(+2.4%) |
| Mar 2015 | - | -47.96%(-8.3%) |
| Dec 2014 | -34.13%(-11.2%) | -52.29%(-10.3%) |
| Sep 2014 | - | -58.27%(-31.8%) |
| Jun 2014 | - | -85.43%(+27.1%) |
| Mar 2014 | - | -67.19%(+74.8%) |
| Dec 2013 | -38.44%(-102.0%) | -38.44% |
| Dec 2012 | 1886.08% | - |
FAQ
- What is Altamira Therapeutics annual return on equity?
- What is the all time high annual ROE for Altamira Therapeutics?
- What is Altamira Therapeutics annual ROE year-on-year change?
- What is the all time high quarterly ROE for Altamira Therapeutics?
What is Altamira Therapeutics annual return on equity?
The current annual ROE of CYTO is 1905.22%
What is the all time high annual ROE for Altamira Therapeutics?
Altamira Therapeutics all-time high annual return on equity is 1905.22%
What is Altamira Therapeutics annual ROE year-on-year change?
Over the past year, CYTO annual return on equity has changed by +2956.25% (+281.27%)
What is the all time high quarterly ROE for Altamira Therapeutics?
Altamira Therapeutics all-time high quarterly return on equity is 2237.91%